Transit worker, a COVID-19 survivor, describes her experience as 'humbling.'
“I love driving; it's therapeutic to me,” House told ABC News. “I'm in my own space.”swept through the country, House witnessed the virus creep into her community.
“Within all the city employee agencies, MTA had the highest death rate from this COVID,” House said. “We are still city employees that are on a daily basis working with the public face to face.” House and her coworkers have adjusted to new schedules and protocols that have been developed in response to the COVID-19 crisis. Rather than working a typical work week of five days on and two days off, she now works five days on and nine days off. House said that this was done to account for operators falling ill and to assure they had enough operators to still service passengers, although ridership has gone down significantly.
The last photo House has on her phone from before her world changed due to the COVID-19 crisis is from a trip she took with her union to Albany, New York, to discuss various worker protections. House has described her experience during the pandemic as “humbling” and said that it made her appreciate life in new ways. She thinks she is going to come out of this experience a better person.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
After Pakistan's lockdown gamble, COVID-19 cases surgeFour weeks ago, with its most important festival coming up and millions of people facing starvation as economic activity dwindled, Pakistan lifted a two-month-long coronavirus lockdown.
Read more »
Novavax's stock soars after DoD contract to make its COVID-19 vaccine candidateShares of Novavax Inc. soared 14% in premarket trading Friday, after the biotechnology company said it was awarded a contract by the U.S. Department of Defense to manufacture its NVX‑CoV2373 COVID-19 vaccine candidate. The DoD has agreed to provide Novavax with up to $60 million to fund the production of several components of the potential vaccine in the U.S. As part of the contract, announced late Thursday, Novavax agreed to delivery in 2020 10 million doses of NVX‑CoV2373 for DoD that could be used in phase 2/3 clinical trials, or under an Emergency Use Authorization if approved by the Food and Drug Administration. On Friday, J.P. Morgan analyst analyst Eric Joseph upgraded Novavax's stock to neutral from underweight, while reiterating his $46 stock price target, saying current share price levels reflect the potential promise for the COVID-19 vaccine program. The stock has rocketed more than 11-fold year to date through Thursday (up 1,022%), while the S&P 500 has slipped 3.7%.
Read more »
Bombardier to cut 2,500 aviation jobs as COVID-19 hurts salesCanadian business jet maker Bombardier Inc said on Friday it would cut 2,500 jobs at its aviation unit and take a related charge of $40 million this year, as the COVID-19 pandemic hurts sales.
Read more »
COVID-19 Is a Symptom of a Bigger Problem: Our Planet’s Ailing HealthOn World Environment Day, Inger Andersen and Johan Rockström explain how the COVID-19 pandemic is a sign of bigger problems with the Earth.
Read more »
Because of COVID-19 pandemic Navy to start 'safe haven' ports of call for its shipsIn an effort to keep a 'COVID-free bubble' for its sailors at sea during the pandemic, the Navy will only allow ports of call at a select number of Navy bases around the world that will serve as 'safe havens.'
Read more »
2 billion doses of Oxford COVID-19 vaccine planned after Gates funding - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Read more »